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A B S T R A C T
Dermatomycosis causes highly frequent dermal lesions, and volatile oils have been proven 
to be promising as antifungal agents. The antifungal activity of geraniol, nerol, citral, ner-
al and geranial (monoterpenes), and terbinafine and anidulafungin (control drugs) against 
seven opportunistic pathogenic yeasts and four dermatophyte species was evaluated by the 
Clinical and Laboratory Standards Institute microdilution tests. Monoterpenes were more 
active against dermatophytes than yeasts (geometric mean of minimal inhibitory concen-
tration (GMIC) of 34.5 and 100.4 μg.ml-1, respectively). Trichophyton rubrum was the fungal 
species most sensitive to monoterpenes (GMIC of 22.9 μg.ml-1). The trans isomers showed 
higher antifungal activity than the cis. The mechanism of action was investigated evalu-
ating damage in the fungal cell wall (Sorbitol Protection Assay) and in the cell membrane 
(Ergosterol Affinity Assay). No changes were observed in the MIC of monoterpenes in the 
sorbitol protection assay. The MIC of citral and geraniol was increased from 32 to 160 μg.ml-1 
when the exogenous ergosterol concentrations was zero and 250 μg.ml-1, respectively. The 
monoterpenes showed an affinity for ergosterol relating their mechanism of action to cell 
membrane destabilization.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
Introduction
Human mycoses are caused by primary pathogenic fungi 
that invade the tissues of a normal host, or by opportunistic 
fungi that invade the tissues of individuals with severe 
alterations in the immune system. Dermatomycosis is one 
of the most frequent dermal lesions that affect humans 
and animals, and is often caused by dermatophytes of the 
genera Epidermophyton, Microsporum and Trichophyton. These 
fungi infect keratinized tissue such as skin, nails and scalp, 
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and their lesions are characterized by irritation, scaling, 
local redness, swelling and inflammation (Kyle and Dahl, 
2004; Gupta and Cooper, 2008; Patel and Schwartz, 2011). 
Meanwhile, some dermatomycoses may be associated with 
the presence of opportunistic yeast pathogens, including 
genus Candida, that can quickly colonize damaged nails or 
skin, especially the mucous membranes (Eggimann et al., 
2003). 
Citral (CIT), geraniol (GOL) and nerol (NOL) are monoterpenes 
constituents of volatile oils. CIT is a mixture of two geometric 
isomers, neral (NAL, cis isomer) and geranial (GAL, trans isomer). 
CIT obtained by organic synthesis has similar percentages of its 
isomers, whereas the volatile oils obtained by extraction from 
plant sources have a higher content of geranial (GAL:NAL (4:3)) 
(Weisheimer et al., 2010). 
The diversity of medicinal plants contributes to several 
studies that aim to demonstrate the action and effectiveness of 
some compounds against fungi. It is worth noting that volatile 
oils containing CIT, GOL and NOL, have proved promising, and 
may be incorporated into pharmaceutical preparations, alone 
or in combination (Prasad et al., 2010; Saddiq and Khayyat, 
2010; Zore et al., 2011a; Miron et al., 2014a).
The mechanism of action of monoterpenes has not been 
completely clarified. Some studies showed the breakdown 
of cytoplasmic and organelle membranes exposed to certain 
volatile oils. The loss of membrane integrity can cause changes 
in membrane function leading to the antifungal activity 
(Sikkema et al., 1995; Pinto et al., 2006; Park et al., 2009). Despite 
these findings, it is not known how volatile oils damage the 
membranes. The discovery of the mechanism of action can help 
maximize the effect of natural products, either by concentration 
of active ingredients or formulation optimization. 
Considering the significance of dermatomycosis and 
candidiasis as prevalent diseases (Ghannoum et al., 2000; 
Caputo et al., 2001), the present study was undertaken to 
establish the antifungal activity of some monoterpenes 
found in volatile oils (GOL, NOL, GAL, NAL and CIT) and 
to investigate possible mechanisms of action for these 
substances.
Material and methods
Reagents
CIT 98.7% (containing 47.6% and 49.1% of NAL and GAL, 
respectively), GOL 99%, NOL 99% and ergosterol were 
purchased from Sigma-Aldrich® (Brazil). Lemongrass oil 
from Cymbopogon citratus was obtained from Ferquima (São 
Paulo, Brasil). Ecalta® (anidulafungin - AFG) was purchased 
from Pfizer® (USA) and each 1 g of injectable product 
contains 100 mg of AFG. Terbinafine hydrochloride (TBF) 
100% and amphotericin B (AMP) 972 μg.mg-1 were kindly 
supplied by Cristália® (Brazil). Methanol (Tedia®, HPLC 
grade) and water filtered through a Milli-Q purification 
system (Millipore®) were used for HPLC mobile phase 
preparation. RPMI 1640 medium containing L-glutamine, 
without sodium bicarbonate, Sigma-Aldrich® (USA), and 
buffered to pH 7.0 with MOPS buffer (Sigma®).
Isolates 
The set of isolates included yeasts: Candida albicans, Candida 
krusei, Candida glabrata, Candida tropicalis, Candida parapsilosis, 
Cryptococcus neoformans, Trichosporon asahii; and dermatophytes, 
Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum 
canis and Microsporum gypseum, from the culture collections 
of the Laboratory of Applied Mycological Research - Federal 
University of Rio Grande do Sul (LAMR-UFRGS).
Inocula preparation
Inocula were prepared according to M27-A3 and M38-A2 
documents determined by the National Committee for 
Clinical Laboratory Standards (NCCLS, 2008a,b). Briefly, stock 
filamentous fungi inocula suspensions were prepared from 
7-day cultures grown on potato dextrose agar (Oxoid) and 
adjusted in sterile saline 0.9% spectrophotometrically to optical 
densities that ranged from 0.085 to 0.100 (approximately 80 to 
82% transmittance) and diluted (1:50) in RPMI 1640 with MOPS 
buffer (RPMI-MOPS). Yeasts were grown on Sabouraud Dextrose 
Agar (Oxoid) for 48 h at 35°C and standardized to the turbidity 
of a 0.5 McFarland standard, and diluted 1:50 in saline followed 
by dilution 1:20 in RPMI-MOPS.
Microdilution assay
Minimal inhibitory concentration (MIC) values were 
determined by broth microdilution using the twofold dilution 
method according to the NCCLS guidelines with RPMI-MOPS. 
Monoterpenes (CIT, GOL and NOL), isomers of CIT (GAL and 
NAL) and antifungal drugs (TBF and AFG) were tested in the 
range of 0.25 to 128 μg.ml-1. Afterwards, 100 μl were inoculated 
into all but the negative control wells of a flat-bottom 96-well 
microtiter plate with each drug concentration range. The 
plates were incubated for 48 h at 35°C for the yeast; fungi and 
dermatophytes were incubated for seven days at the same 
temperature. All assays were tested in triplicate. The MIC was 
defined as the lowest concentration of compound at which 
the microorganism tested did not demonstrate visible growth.
Mechanism of action
Sorbitol Protection Assay
MIC values were determined using T. asahii TAH10, by the 
standard broth microdilution procedure described above. 
Duplicate plates were prepared: one of them containing two-
fold dilutions of AFG (positive control), CIT, GOL or NOL from 1 
to 256 μg.ml-1 and the other contained the same concentrations 
plus 0.8 mol.l-1 sorbitol. MIC was determined after 2 and 7 days.
Ergosterol Effect Assay
MIC of AMP (positive control), CIT, GOL or NOL against T. assahii 
TAH10 was determined following the guidelines of NCCLS as 
explained above, in the absence and in the presence of different 
concentrations (0, 50, 100, 150, 200 and 250 μg.ml-1) of ergosterol 
added to the assay medium, in different lines of the same 
microplate. The antifungals were added to reach the following 
final concentrations: 0.125, 0.25, 0.5 or 1.0 μg.ml-1 for AMP and 
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32, 64, 96, 128 or 160 μg.ml-1 for monoterpenes. The MIC was 
determined after 24 h according to the control fungal growth 
and further confirmed after 48 h.
Purification of citral isomers
Samples of standard CIT and lemongrass oil were subjected to 
analysis by Gas Chromatography – Flame Ionization Detection 
(GC-FID), as described in the Lemongrass monograph present in 
the Brazilian Pharmacopoeia (Farmacopeia Brasileira, 2010). The 
analyses were performed on a Perkin Elmer gas chromatograph 
model Autosystem XL (Shelton, USA).
Citral isomers (GAL and NAL) were isolated/purified from 
CIT solution (12 mg.ml-1) and identified by a high-performance 
liquid chromatography (HPLC) method adapted from Miron et 
al. (2012). Purification was performed in an Agilent instrument 
(series 1200) using a reversed phase ACE® RP18 column (250 × 
4 mm, 5 μm particle size). The system was set with a mobile 
phase consisting of methanol and water (67:33, v/v), injection 
volume was 50 μl, and flow rate 1.4 ml.min-1. The CIT isomers 
were detected at 270 nm and the apex peak of each isomer 
was collected separately in glass tubes. The purified isomers 
were subsequently quantified with the same HPLC method 
(detection at 240 nm and injection volume 20 μl). Peak purity 
analysis was performed using the wavelength range of 200-300 
nm, standard deviation of noise determined at 0.2 min with 50 
spectra, reference spectra set in automatic mode and purity 
level calculated with apex spectrum.
Statistical analysis
Statistical analysis was carried out using Prism 5 statistical 
analysis software for Windows (GraphPad software®). MIC data 
were used to compare the activity of the antifungal agents 
using a non-parametric statistical test (Mann-Whitney Test). 
The geometric mean MIC (GMIC) was employed to summarize 
results. The values of MIC > 128 μg.ml-1 were replaced by 
256 μg.ml-1 to enable the calculation and thus avoid the 
underestimation of GMIC by deletion of data.    
Results 
Purification of citral isomers
The analysis by GC-FID was performed to identify and quantify 
NAL and GAL in the CIT standard and the lemongrass oil. The 
identification of CIT isomers was achieved by comparing the 
experimental results of Kovats Index to the values established 
by the Brazilian Pharmacopoeia. NAL showed lower retention 
time (10.1 min) than GAL (10.7 min). The relative percentage 
area of the chromatogram peaks of NAL and GAL was calculated 
by electronic integration. The CIT standard showed 47.6 and 
49.1% of NAL and GAL, respectively, whereas lemongrass oil 
had 33.5 and 44.6%. For CIT standard, NAL and GAL had similar 
peak intensities. Nevertheless, for the lemongrass oil, GAL 
showed a more intense peak than NAL. 
The lemongrass oil analysis by HPLC at 240 nm showed 
the highest peak with retention time at 9.5 min, which was 
identified as GAL. A second peak, less intense, at 8.5 min was 
assigned to NAL.
NAL and GAL were purified by HPLC from a CIT standard 
solution containing 12 mg.ml-1 (Fig. 1a). The injection of the 
highly concentrated CIT solution was monitored at 270 nm 
to minimize the greater absorptivity of NAL and GAL at 240 
nm. Four drops from the peak apex were collected in different 
tubes for each one of the isomers. This small volume collected 
allowed having purified isomers in concentrations greater than 
1.3 mg.ml-1. NAL and GAL obtained by purification were diluted 
with water to a concentration of 256 μg.ml-1. Thus, the initial 
concentrations of GAL and NAL in the microdilution test were 
128 μg.ml-1 with less than 7% methanol. 
Purified isomers quantification was performed at 240 nm 
of the diluted samples (Fig. 1c) comparing its results to CIT 
standard solution (~ 0.00952 and 0.00982 mg.ml-1 of NAL and 
GAL, respectively). The purification of NAL results in solutions 
with higher concentrations (1.35-1.51 mg.ml-1) than GAL (1.30-
1.39 mg.ml-1). The purity of the solutions containing the isolated 
isomers was estimated from the relative percentage area of 
the peaks in the chromatograms at 240 nm. Calculated purity 
percentages of NAL and GAL were 98.4% and 97.9%, respectively.
Purified and undiluted NAL and GAL were stable at 4°C for 
at least 72 h. The peak purity analysis did not detect impurities 
for the samples of NAL and GAL stored for 72 h at 4°C (Fig. 
1d). The analysis of the same samples after five days showed 
impurities co-eluting with NAL (the similarity curve intersected 
the threshold curve) though the reduction in the concentration 
of the drugs was not significant (Fig. 1e). Keeping the purified 
isomers at room temperature during 48 h causes over 5% 
reduction of content.
In vitro activity
The isolates of yeasts tested in this study exhibited different 
sensitivities against monoterpenes (Table 1). CIT was more 
active against C. neoformans and T. asahii; however, CIT showed 
lower MIC against Candida species than its isolated isomers. 
The results of GOL and NOL against yeasts were not impressive, 
especially for Candida species. It should be mentioned that all 
yeast strains were susceptible to CIT in the concentration range 
evaluated (0.25 – 128 μg.ml-1). 
For dermatophyte isolates, the greatest effect of 
monoterpenes was observed against T. rubrum (GMIC of 22.9 
μg.ml-1). GOL and CIT were the most active monoterpenes 
against Microsporum strains (GMIC of 19.5 and 23.8 μg.ml-1) and 
highly effective against dermatophytes (GMIC of 25.4 and 16.0 
μg.ml-1, respectively). 
In general, the monoterpenes were more active against 
dermatophytes than yeasts (Fig. 2). The GMIC of monoterpenes 
were 34.5 and 100.4 μg.ml-1 for dermatophytes and yeasts, 
respectively.
CIT was active against all strains of yeasts and 
dermatophytes. GOL and GAL had intermediate activity, 
similar to CIT in many strains. Furthermore, trans isomers (GOL 
and GAL) showed greater activity than cis isomers (NOL and 
GOL). The Mann-Whitney test showed a statistical difference 
between MIC of trans and cis isomers (p = 0.007) with GMIC of 
56.3 and 99.0 μg.ml-1, respectively. 
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Figure 1 – Chromatograms, UV spectra and peak purity analysis of citral isomers. A. Chromatogram at 270 nm of high concentrated 
citral solution used to neral and geranial purification; B. UV spectra of neral and geranial; C. Chromatogram at 240 nm of citral stan-
dard and neral and geranial purified; D. Peak purity analysis of neral after 72 h of storage at 4°C – impurity not detected; E. Peak purity 
analysis of neral after five days of storage at 4°C – impurity detected. 
MIC (μg.ml-1)
Microorganism NAL GAL CIT NOL GOL TBF
T. rubrum (n = 5) 32 (128,16) 8 (128,2) 4 (64,2) 64 (64,32) 64 (64,2) 0.25 (0.25,0.25)
T. menthagrophytes (n = 3) 128 (128,16) 32 (64,8) 32 (128,2) 128 (128,64) 32 (64,32) 2 (4,0.25)
M. canis (n = 4) 80 (>128,32) 48 (128,16) 48 (64,16) 128 (128,128) 40 (64,1) 0.25 (4,0.25)
M. gypseum (n = 3) >128 (>128,32) 32 (>128,16) 16 (128,1) 128 (128,1) 128 (128,1) 0.25 (0.5,0.25)
NAL GAL CIT NOL GOL AFG
C. albicans (n = 3) >128 (>128, >128) >128 (>128, >128) 64 (128,64) >128 (>128,128) >128 (>128,128) 8 (8,0.25)
C. Krusei (n = 3) >128 (>128, >128) >128 (>128,64) 64 (64,64) 128 (128,128) 128 (128,64) 0.5 (32,0.25)
C. glabrata (n = 3) 64 (>128,32) 64 (64,64) 64 (128,64) >128 (>128,128) >128 (128,32) 0.5 (4,0.25)
C. tropicalis (n = 3) >128 (>128, >128) >128 (>128,128) 64 (128,64) >128 (>128,128) 128 (128,128) 4 (32,2)
C. parapsilosis (n = 3) >128 (>128,128) 64 (>128,32) 64 (128,64) 128 (128,64) 128 (128,64) 2 (2,0.25)
T. asahii (n = 3) 128 (>128,64) 128 (128,64) 32 (64,32) 64 (128,32) 128 (128,32) 0.25 (4,0.25)
C. neoformans (n = 2) 17 (32,2) 8.5 (16,1) 12 (16,8) 128 (128,128) 72 (128,16) 1.1 (2,0.25)
Table 1
Susceptibility of yeast and dermatophytes against monoterpenes (NAL, GAL, CIT, NOL and GOL) and control drugs (AFG and 
TBF). Median MIC in μg.ml-1 (the results in brackets represent the maximum and minimum MIC for each species).
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Sorbitol in 
the media 
(mol.l-1)
MIC (μg.ml-1)
AFG 
(control)
CIT GOL NOL
0.0
Day 2 1 32 32 32
Day 7 1 32 32 32
0.8
Day 2 1 32 32 32
Day 7 128 32 32 32
Table 2
MIC values (μg.ml-1) of monoterpenes (CIT, GOL and NOL) 
and anidulafungin (AFG) against T. asahii TAH10 in the 
Sorbitol Protection Assay.
Mechanism of action
The MIC of the positive control (AFG), in the sorbitol 
protection assay, was increased by the presence of sorbitol 
(Table 2). However, after seven days of incubation, the MIC of 
monoterpenes did not increase. Morphological analysis of the 
microorganisms not treated with antifungals showed perfect 
of exogenous ergosterol, equal or greater than 100 μg.ml-1, 
increased the MIC of AMP; and at concentrations of 150 μg.ml-1 
of ergosterol in the medium, the MIC of AMP has increased 
eight-fold.   
Discussion
Purification of citral isomers
Isomers were identified from information obtained from analysis 
by GC-FID of the CIT standard and sample of lemongrass oil 
which showed greater amount of GAL than NAL (relation of 
4:3 was found). The peak with higher intensity in the analysis 
of the lemongrass oil by HPLC-UV was identified as GAL. The 
comparison with CIT standard solution allowed the identification 
of NAL peak. Furthermore, Miron et al (2012) showed that GAL and 
NAL can be identified by UV analysis since the trans isomer GAL 
has greater maximum in the UV spectrum (Fig. 1b).
Figure 2 – Geometric mean of minimum inhibitory concentration (GMIC) of monoterpenes against yeasts and dermatophytes, and 
95% confidence interval.
Figure 3 – Optical microscopy of T. asahii after seven days of in-
cubation in culture medium (a) no antifungal, (b) medium with 
AFG and sorbitol.
yeast cells in reproduction (Fig. 3). Cells treated with AFG and 
sorbitol, after seven days, are viable and recover their growth, 
but dysmorphic cells still occur due to damage to the cell wall. 
Sorbitol has no effect on monoterpene activity and, even after 
seven days, there was no microorganism growth.
In the “Affinity Ergosterol Assay”, AMP and monoterpenes 
had their MIC increased since larger amounts of exogenous 
ergosterol were added to medium (Fig. 4). When ergosterol 
ranged from 0 to 250 μg.ml-1 in the growth medium, MIC for 
monoterpenes increased from 32 to 160 μg.ml-1. Concentrations 
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Essential oils, including CIT (Log Po/w 2.8-3.0), have 
pronounced lipophilic properties (OECD, 2001). Therefore, a 
large amount of the organic phase (67% methanol) was used 
for elution of the isomers (NAL and GAL). In this context, 
it was essential to collect small volumes of the apex of the 
chromatographic peak yielding high concentrations of the 
isolated isomers. This allowed a large dilution (at least 1:10) 
of the isolated isomers such that the final concentration of 
methanol in the tests of microbiological activity was less than 
7% (there was no growth inhibition at this concentration of 
methanol for any of the strains tested). 
CIT and its isomers are aldehydes that can be unstable in 
aqueous solution (Choi et al., 2009; Miron et al., 2014b). The 
CIT isomers were stored at 4°C because of its great instability 
at room temperature (more than 5% is degraded in 48 h). Peak 
purity analysis is a very sensitive tool and detected a co-eluting 
compound along NAL peak after 120 h of storage at 4°C. The 
purification/isolation process did not last more than 8 h. The 
purified isomers were kept in a refrigerator in a tight glass flask 
and used within 48 h after extraction in the microbiological 
assays. This procedure was used to minimize the effect of the 
instability of the CIT isomers and to ensure reproducibility of 
the results. For the same reason, CIT solutions were prepared 
at the same time of the purification process of its isomers to 
control any time effect on the microbiological assays. NOL 
and GOL are alcohols and previous studies did not show any 
stability problems in aqueous solution and in temperatures 
around 32°C (Miron et al., 2014a). 
In vitro activity
CIT was the monoterpene with greater antifungal activity 
against yeasts. These results are consistent with results from 
Sajjad et al. (2012) and Zore et al. (2011a,b) that showed lower 
MIC values to CIT than to GOL.
CIT and its isomers were very effective against T. rubrum, 
which causes most cases of onychomycosis (Thomas et al., 
2010; Nazar et al., 2012). Microsporum species infect animals 
more frequently than humans, but reports have shown that 
dogs and cats can transmit these microorganisms to man 
(Segundo et al., 2004; Grills et al., 2007). GOL and CIT lead 
the antifungal activity against this species as well as against 
dermatophytes in general.
Many studies on volatile oils evaluate the activity of 
monoterpenes against Candida species, probably due to its 
clinical relevance (Sajjad et al., 2012; Zore et al., 2011a,b). 
Despite this, our study demonstrated that monoterpenes were 
more active against dermatophytes than yeasts. These results 
are promising, demonstrating the potential of monoterpenes 
against dermatophyte species.
Mechanism of action
The Sorbitol Protection Assay was performed to test the effect 
of monoterpenes on the integrity of the fungal cell wall (Frost 
et al., 1995). In this assay, MIC determinations were conducted 
with and without 0.8 mol.l-1 sorbitol. Specific T. asahii strain 
TAH10 (Internal laboratory identification) was used because of 
its known sensitivity to AFG and other terpenes. Note that this 
specific strain was not tested in the antifungal activity assay 
and its MIC results are not presented in the Table 1. 
Sorbitol is an osmotic protectant used for stabilizing fungal 
protoplasts and it is expected that the MIC of a compound that 
damages the cell wall will shift to a much higher value in the 
presence of the osmotic support. No variations in MIC were 
observed for monoterpenes in this assay suggesting that CIT, 
GOL and NOL would not act by inhibiting control of cell wall 
synthesis or assembly mechanisms. 
To determine if monoterpenes bind to ergosterol, the assay 
based on the effect of exogenous ergosterol was performed. 
The affinity of a molecule with ergosterol can be established by 
determining the MIC in the presence of exogenous ergosterol in 
the extracellular media. If the compound binds to ergosterol, it 
will rapidly form a complex, preventing the cellular membrane 
from interacting with ergosterol. Consequently the observed 
MIC increases. 
The MIC for monoterpenes increased five-fold in the 
presence of exogenous ergosterol revealing that CIT, GOL and 
NOL bind to the main sterol of fungal membranes. AMP also 
interacts with ergosterol, and at concentrations of 200 μg.ml-1 
of sterol there was no more inhibition caused by AMP. This 
is probably due the large relative concentration of ergosterol 
Figure 4 – Effect of exogenous ergosterol (50-250 μg.ml−1) on the MIC of (a) amphotericin B and (b) monoterpenes against T. asahii 
(strain TAH10).  
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that result in very low concentrations of free AMP and, 
consequently, no inhibition of fungal growth.
The mechanism of action of AMP has recently been 
associated to sterol binding and channel formation (classical 
known mechanism of action) seems to be only one of 
multiple sterol-binding-dependent mechanism of action 
(Palacios et al., 2011; Wilcock et al., 2013). Park et al. (2009) 
reported the effect of citral at the cellular level in a strain of T. 
menthagrophytes employing the Scanning Electron Microscopy 
(SEM) and Transmission Electron Microscopy (TEM) techniques. 
The authors found less thickness and the presence of 
discontinuities in the cellular membrane, concluding that the 
membrane was degraded. The results at high concentrations 
of terpenes (citral, eugenol, nerolidol and D-pinene) also show 
the breakdown of the cell membrane, along with abnormalities 
in the structure of mitochondria. 
The positive results of monoterpenes on the “Affinity 
Ergosterol Assay” and the other reports on the subject strongly 
suggest that the mechanism of action of this class of drugs is 
related to ergosterol-binding and a subsequent destabilization 
of fungal cell membranes.
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